News Announcement

Fresenius Kabi Oncology: Delisting Update

With reference to the earlier letter dated October 14, 2013 regarding Delisting Update, Fresenius Kabi Oncology Ltd has now informed BSE that the Company had filed a Miscellaneous Application No. 113 of 2013 in Appeal No. 133 of 2013 before the Honble Securities Appellate Tribunal (SAT) seeking an extension of time to complete the Delisting Offer. The Honble SAT disposed off the SAT Application on October 18, 2013.

An order was passed in the open court granting the Company an extension of 2 months from October 22, 2013 for completing the Delisting Offer. A copy of the SAT Order will be disseminated once the Company receives the same.

Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.


These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan